Private Advisor Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.33M Sell
14,681
-913
-6% -$83.8K 0.01% 1252
2025
Q4
$1.4M Buy
15,594
+500
+3% +$47.4K 0.01% 1215
2025
Q3
$1.49M Buy
15,094
+1,319
+10% +$131K 0.01% 1148
2025
Q2
$1.26M Sell
13,775
-304
-2% -$29.4K 0.01% 1188
2025
Q1
$1.59M Buy
14,079
+200
+1% +$21.4K 0.01% 1006
2024
Q4
$1.47M Buy
13,879
+2,822
+26% +$303K 0.01% 1026
2024
Q3
$1.19M Sell
11,057
-965
-8% -$105K 0.01% 1156
2024
Q2
$1.3M Buy
12,022
+1,176
+11% +$139K 0.01% 1050
2024
Q1
$1.43M Buy
10,846
+236
+2% +$29.5K 0.01% 982
2023
Q4
$1.29M Buy
10,610
+1,164
+12% +$130K 0.01% 983
2023
Q3
$1.06M Sell
9,446
-29
-0.3% -$3.68K 0.01% 1015
2023
Q2
$1.36M Buy
9,475
+91
+1% +$12.4K 0.01% 899
2023
Q1
$1.21M Buy
9,384
+453
+5% +$56.9K 0.01% 908
2022
Q4
$296K Sell
8,931
-882
-9% -$102K 0.01% 754
2022
Q3
$1.03M Sell
9,813
-328
-3% -$36K 0.01% 910
2022
Q2
$1.06M Sell
10,141
-615
-6% -$73K 0.01% 1031
2022
Q1
$1.38M Buy
10,756
+1,630
+18% +$196K 0.01% 954
2021
Q4
$1.13M Sell
9,126
-4,467
-33% -$585K 0.01% 1074
2021
Q3
$1.93M Buy
13,593
+7,080
+109% +$1.04M 0.01% 898
2021
Q2
$1.02M Sell
6,513
-2,153
-25% -$349K 0.01% 1061
2021
Q1
$1.35M Sell
8,666
-398
-4% -$61.7K 0.01% 873
2020
Q4
$1.36M Buy
9,064
+1,929
+27% +$272K 0.01% 787
2020
Q3
$943K Sell
7,135
-109
-2% -$14.2K 0.01% 802
2020
Q2
$839K Buy
7,244
+618
+9% +$71.2K 0.01% 831
2020
Q1
$650K Buy
6,626
+627
+10% +$82.2K 0.01% 804
2019
Q4
$872K Sell
5,999
-2,334
-28% -$322K 0.01% 821
2019
Q3
$1.11M Sell
8,333
-944
-10% -$122K 0.02% 753
2019
Q2
$1.06M Buy
9,277
+844
+10% +$98.9K 0.02% 716
2019
Q1
$1.05M Buy
8,433
+2,279
+37% +$259K 0.02% 640
2018
Q4
$619K Buy
6,154
+73
+1% +$8.21K 0.01% 759
2018
Q3
$776K Sell
6,081
-826
-12% -$98.2K 0.02% 796
2018
Q2
$749K Buy
6,907
+4,708
+214% +$512K 0.01% 585
2018
Q1
$232K Sell
2,199
-3,850
-64% -$447K 0.01% 990
2017
Q4
$740K Sell
6,049
-886
-13% -$100K 0.03% 494
2017
Q3
$791K Buy
6,935
+1,089
+19% +$126K 0.02% 660
2017
Q2
$723K Sell
5,846
-561
-9% -$66.5K 0.02% 674
2017
Q1
$748K Sell
6,407
-117
-2% -$13.3K 0.02% 639
2016
Q4
$726K Buy
6,524
+2,188
+50% +$235K 0.02% 601
2016
Q3
$544K Sell
4,336
-1,599
-27% -$198K 0.02% 619
2016
Q2
$702K Buy
5,935
+626
+12% +$70.8K 0.03% 511
2016
Q1
$518K Sell
5,309
-247
-4% -$23.9K 0.03% 564
2015
Q4
$553K Sell
5,556
-825
-13% -$80.7K 0.03% 571
2015
Q3
$582K Buy
6,381
+3,840
+151% +$385K 0.03% 520
2015
Q2
$269K Buy
2,541
+543
+27% +$60.1K 0.01% 829
2015
Q1
$228K Buy
+1,998
New +$228K 0.01% 835
2014
Q4
Sell
-2,080
Closed -$203K 1314
2014
Q3
$203K Buy
+2,080
New +$205K 0.01% 844
2014
Q2
Sell
-2,879
Closed -$264K 967
2014
Q1
$264K Buy
+2,879
New +$265K 0.03% 611

Other funds holding ZBH

Private Advisor Group's ZBH Position: Q1 2026 in Review

Private Advisor Group reduced its Zimmer Biomet (ZBH) stake by 5.9% in Q1 2026, selling an estimated $83.8K and leaving 14,681 shares worth $1.33M. The position accounts for 0.01% of the portfolio, ranked #1252.

Private Advisor Group first reported a position in ZBH in Q1 2014 and has held it in 47 quarters since. The position peaked at $1.93M in Q3 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Private Advisor Group held 14,681 shares of Zimmer Biomet worth $1.33M as of Q1 2026.
  • Private Advisor Group sold 913 Zimmer Biomet shares in Q1 2026, an estimated $83.8K.
  • Zimmer Biomet made up 0.01% of Private Advisor Group's portfolio in Q1 2026, its #1252 holding.
  • Private Advisor Group first reported a position in Zimmer Biomet in Q1 2014 and has held it in 47 quarters since.
  • Private Advisor Group's Zimmer Biomet position peaked at $1.93M in Q3 2021.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.